Drawing for Serial No. 88357875

USPTO serial 88357875

Serial No. 88357875

Reviewed by CopyMark Law Group

Reg. 6316240Status 700Renewal
Filing date
Status date
Registration date
Apr 6, 2021
Examiner
JENKINS JR, CHARLES L
Law office
PUBLICATION AND ISSUE SECTION

What this means

This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.

Status 700: Status 700 means the trademark is registered and active on the Principal Register. You have nationwide rights for the listed goods and services and may use ®. Section 8 maintenance is due between years five and six.

Need help with Serial No. 88357875?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*

Plus Government fees of $1,950

Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Lynne Graybeal

Lynne Graybeal PERKINS COIE LLP1201 THIRD AVENUE, SUITE 4900SEATTLE, WA 98101UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
016Medical identification cards, not magnetically encoded; medical identification cards, not magnetically encoded for use in connection with payment for prescription medication; discount prescription drug cards, not magnetically encodedACTIVE—
035Advisory and consulting services in the field of cost management of health care and pharmaceuticals; advisory and consulting services in the field of health care and pharmaceutical benefit programs; advisory and consulting services in the field of health care and pharmaceutical regulatory compliance; pharmaceutical cost management advisory and consulting services regarding the administration of the federal 340B prescription drug discount program and maximization of benefits; providing an online computer database for collecting and reporting pharmacy management and drug dispensing information for business purposes; data management services, namely, electronic data collection, online claims management, and financial reconciliation of accounts on behalf of others; administration coordination services in the nature of facilitating administrative coordination between health care facilities, pharmacies, and insurance plans; inventory management; Business consulting services in the fields of the business management and administration of Federal 340B pharmacy programs and discount prescription drug programs; business management and administration of Federal 340B pharmaceutical programs and discount prescription drug programs; Business and Inventory management services provided to eligible organizations in the healthcare fields for controlling drug inventories; business and inventory management services provided to eligible pharmacies for controlling drug inventories; business assistance, advisory services, and consultancy in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; business consulting services, relating to operations management services, managing the flow of inventory, business information, and accounts receivable billing between health centers, pharmacies, wholesalers, and insurance companies; business assistance, advisory services, and consultancy, namely, assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodies for business purposes; audit support services, namely, audit policy and procedures guidance, review of audit documents, data and procedures, preparation, organization, and presentation of the documents and data requested by a government body or third party, and providing business advice on government or third party audit processes, policies, and strategies; specialty retail pharmacy services; interactive record-keeping services for use in regulatory compliance by professionals in the healthcare, medical and pharmaceutical fields; Consulting services in the field of pharmaceutical cost management services and drug utilization review servicesACTIVE—
036Health care and pharmacy benefits claims recovery services in the nature of insurance subrogation, namely, coordination of insurance benefits programs claims processing and administration; Insurance administration services, namely, insurance subrogation and assisting others with collecting insurance premiums in the nature of the collection of money owed by patients and insurance providers; pharmacy benefit management services; pharmacy benefit and claims processing management services; Consulting services in the fields of healthcare benefits; Consulting services in the fields of pharmacy and prescription medication benefits; consulting services in the field of pharmaceutical benefit management services; consulting services in the field of pharmaceutical benefit management services of Federal 340B pharmacy programs, and discount prescription drug programsACTIVE—
042Software as a Service (SAAS) services featuring software for use with managing medical and pharmaceutical records and data; computer services, namely, providing search engine services for obtaining and managing medical and pharmaceuticals records and data on a global computer network; Software as a Service (SAAS) services featuring software for cost management in the field of health care and pharmaceuticals; software as a service (SAAS) services featuring software for use with self-auditing company records to ensure compliance with and maximizing the benefits of health care and pharmaceutical benefit programs; software as a service (SAAS) services featuring software for administering and maximizing the use of the federal 340B prescription drug discount program through organization of information and implementation of automated duty allocation, automated risk scoring, and expert-defined tasks and assessment steps; Software as a Service (SaaS) services, namely, providing non-downloadable computer software and applications for drug and pharmaceutical inventory management, tracking, managing, and reporting of information, and regulatory compliance and requirements in connection with Federal 340B pharmacy programs and discount prescription drug programs for eligible organizations and pharmacies to allow them to offer drug distribution services on behalf of covered entities in compliance with Federal 340B pharmacy programs and discount prescription drug programs; Software as a Service (SaaS) services, namely, providing non-downloadable computer software and applications for drug and pharmaceutical inventory management, tracking, managing, reporting of information, split-billing, and regulatory compliance for use by Federally qualified hospitals and other healthcare providers participating in the Federal 340B pharmacy program; Software as a Service (SaaS) services, namely, providing non-downloadable computer software and applications for self-auditing by eligible organizations and pharmacies qualified to participate in the Federal 340B pharmacy programs and discount prescription drug programsACTIVE—
044Medical and pharmaceutical consultationACTIVE—
045Regulatory compliance consulting in the fields of healthcare, pharmaceutical, Federal 340B pharmacy programs, and discount prescription drug programs; regulatory compliance consulting services in the fields of healthcare, pharmaceuticals and Federal 340B pharmaceutical program in the nature of compliance, auditing, and reviewing contracts, systems, procedures, and policies, all for compliance with government regulations; reviewing standards and practices to assure compliance with laws and regulations relating to healthcare and pharmaceutical benefit plans; regulatory compliance consulting in the field of assisting others in preparing and filing applications for eligible health care facilities and pharmacies in the fields of Federal 340B pharmaceutical programs and discount prescription drug programs with governmental regulatory bodiesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Apr 6, 2026REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Apr 6, 2021R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Mar 2, 2021SUNANOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED—
Mar 1, 2021CNPRALLOWED PRINCIPAL REGISTER - SOU ACCEPTED—
Feb 5, 2021SUPCSTATEMENT OF USE PROCESSING COMPLETE—
Nov 25, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
Nov 24, 2020EX2GSOU EXTENSION 2 GRANTED—
Nov 23, 2020AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL—
Nov 11, 2020IUAFUSE AMENDMENT FILED—
Nov 11, 2020EXT2SOU EXTENSION 2 FILED—
Nov 11, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 11, 2020EISUTEAS STATEMENT OF USE RECEIVEDThe applicant filed a Statement of Use with specimens showing the mark in actual commerce. The USPTO will review the filing for compliance. If accepted, the mark can proceed to registration; if deficient, the USPTO may issue a requirement or office action.
Jun 2, 2020EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED—
May 29, 2020EX1GSOU EXTENSION 1 GRANTED—
May 29, 2020EXT1SOU EXTENSION 1 FILED—
May 29, 2020EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Dec 3, 2019NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 8, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 8, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 18, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 5, 2019ALIEASSIGNED TO LIE—
Sep 4, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 31, 2019TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 30, 2019CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 30, 2019TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 12, 2019GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2019GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 12, 2019CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2019DOCKASSIGNED TO EXAMINER—
Apr 13, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Apr 12, 2019TAEATEAS AMENDMENT ENTERED BEFORE ATTORNEY ASSIGNED—
Apr 12, 2019PARITEAS VOLUNTARY AMENDMENT RECEIVED—
Apr 12, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Mar 29, 2019NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance